Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Biopharmaceuticals Go to Market: Patterns of Worldwide Development

Bio/Technology volume 11, pages 168–172 (1993)Cite this article

Abstract

New drugs become available at different rates in different countries. Who's ahead and who's behind?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Wardell, W.M. 1978. The drug lag revisited: Comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1916. Clin. Pharmacol. Ther. 24: 499–524.

    Article  CAS  Google Scholar 

  2. Wardell, W.M. 1973. Introduction of new therapeutic drugs in the United States and Great Britain: An international comparison. Clin. Pharmacol. Ther. 14: 773–790.

    Article  CAS  Google Scholar 

  3. Andersson, F. 1992. The drug lag issue: The debate seen from an international perspective. International Journal of Health Services 22: 53–72.

    Article  CAS  Google Scholar 

  4. Pharma Projectss. 1984–1992. Hutton, I., ed., PJB Publications Ltd., Surrey U.K.

  5. The NDA Pipeline. 1983–1992 F-D-C Reports, Inc., Chevy Chase, MD.

  6. Japan Drug Guide. 1980–1991. Technomic Information Service, Inc., Tokyo.

  7. Bienz-Tadmor, B., DiCerbo, P.A., Tadmor, G. and Lasagna, L. 1992. Biopharmaceuticals and conventional drugs: Clinical success rates. Bio/Technology 10: 521–525.

    CAS  PubMed  Google Scholar 

  8. SCRIP Yearbook. 1991. Pharmabooks Ltd., NY, p. 35.

  9. Shulman, S.R., Bienz-Tadmor, B., Seo, P.S., Dimasi, J.A. and Lasagna, L. 1992. Implementation of the Orphan Drug Act: 1983-1991. Food and Drug Law Journal 47: 363–403.

    Google Scholar 

  10. U.S. Office of Technology Assessment. 1991. Biotechnology in a Global Economy, OTA-BA-494: Government printing office, Washington, D.C., October, p. 4.

  11. Kaitin, K.I., Mattison, N., Northington, F.K. and Lasagna, L. 1989. The drug lag: An update of new drug introductions in the United States and the United Kingdom, 1977 through 1987. Clin. Pharmaml. Ther. 46: 121–138.

    Article  CAS  Google Scholar 

  12. The President's Council on Competitiveness. 1991. Report on national biotechnology policy (February), 11–15.

  13. Bienz-Tadmor, B. 1992. A comparison of development times for biopharmaceuticals and conventional drugs. Bio/Technology (submitted).

  14. Chapekar, M.S. and Gunter, K.C. 1992. FDA regulations for growth factors and related products. In Angiogenesis: Key Prin ciples --Science--Technology--Medicine, Steiner, R., Weisz, P.B. and Langer, R., eds., Birkhauser Verlag, Basel, 471–478.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Center for the Study of Drug Development, Tufts University, 192 South Street, Boston, Massachusetts, 02111

    Brigitta Bienz-Tadmor

Authors
  1. Brigitta Bienz-Tadmor
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bienz-Tadmor, B. Biopharmaceuticals Go to Market: Patterns of Worldwide Development. Nat Biotechnol 11, 168–172 (1993). https://doi.org/10.1038/nbt0293-168

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0293-168

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing